New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors

• Waldemar Debinski ,

  * E-mail: debinski@wakehealth.edu (WD); pjdickinson@ucdavis.edu (PD)

  Affiliation Brain Tumor Center of Excellence, Thomas K. Hearn Brain Tumor Research Center, Departments of Neurosurgery, Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America

  ⨯
• Peter Dickinson ,

  * E-mail: debinski@wakehealth.edu (WD); pjdickinson@ucdavis.edu (PD)

  Affiliation Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California at Davis, Davis, California, United States of America

  ⨯
• John H. Rossmeisl,

  Affiliation Department of Small Animal Clinical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, United States of America

  ⨯
• John Robertson,

  Affiliation Department of Small Animal Clinical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, United States of America

  ⨯
• Denise M. Gibo

  Affiliation Brain Tumor Center of Excellence, Thomas K. Hearn Brain Tumor Research Center, Departments of Neurosurgery, Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America

  ⨯